Clinical Trials Directory

Trials / Completed

CompletedNCT04290286

i2TransHealth: Interdisciplinary, Internet-based Trans Health Care

Interdisciplinary, Internet-based Trans Health Care (i2TransHealth): A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
186 (actual)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

i2TransHealth is a randomized controlled trial that investigates the outcomes of an internet-based health care approach for transgender and gender diverse (TGD) people. As a health services research project, i2TransHealth aims at reducing the structural disadvantage for TGD people \[people with transsexualism (TS: ICD-10), gender incongruence (GIC: ICD-11) and/or gender dysphoria (GD: DSM-5)\] living in areas lacking specialized transition-related treatment. Located at the Institute for Sex Research and in cooperation with the Interdisciplinary Transgender Health Care Center Hamburg (ITHCCH), both University Medical Center Hamburg-Eppendorf (UKE), i2TransHealth is an innovative intervention including video consultation and a 1:1 chat with clinical psychologists. By cooperating with the ITHCCH, general physicians and psychiatrists provide first and local access to the specialized treatment provided by the UKE. In the intervention group, the study participants are invited to use the i2TransHealth e-health platform including a video consultation hour every two weeks and a messenger between the video-meetings. In addition, they have the opportunity to receive medical support close to their home by licensed GPs and psychiatrists according to their needs (especially in case of a somatic or mental health crisis). The waiting group participants will be able to go forward with transition-related care after four months of study participation, as part of regular care. The primary outcome measure is a reduced symptomatology for TGD people (BSCL). Secondary outcome parameters include quality of life and patient satisfaction as well as healthcare-related costs and cost-effectiveness. Finally, based on a longitudinal design, it will be assessed if the physicians improve their TGD-related expertise by cooperating within the i2TransHealth-network.

Conditions

Interventions

TypeNameDescription
OTHERi2TransHealthi2TransHealth: online intervention for TGD people

Timeline

Start date
2020-05-01
Primary completion
2022-05-31
Completion
2022-09-30
First posted
2020-02-28
Last updated
2022-11-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04290286. Inclusion in this directory is not an endorsement.